Cardiomyopathy: Is It All Genetic?

This session with highlight the underutilization of genetic testing within cardiology practices, address institutional barriers for referring patients who would benefit from genetic testing, review the prevalence of pathogenic variants in  more common indications (HCM / DCM) as well in less-considered indications (PPCM, myocarditis, alcohol/ substance, chemo and other exposures), and review how to understand and follow through on genetic results with uncertain variants. Declining costs of gene sequencing have led to broader efforts to sequence exomes and genomes in asymptomatic populations. Recognition of a genetic predisposition to cardiomyopathy should enhance efforts for primary prevention of heart failure.

Agenda

• Moderator - Nosheen Reza, MD, FHFSA
• Moderator - Allison Cirino, MS, CGC
• DCM Genetics: Dealing With Uncertainty - Elizabeth Jordan, MS, LGC
• HCM: Do I Really Need a Genotype? - Neal Lakdawala, MD
• Imagination Will Take You Everywhere: Early Insights From ReIMAGINE HF - Mustafa Ahmed, MD
• Population-Based Genomic Screening for HF Prevention - Daniel Judge, MD, FHFSA
• Panel Discussion